688366.SH
昊海生科
SSE · Healthcare · Biotechnology · CN
CNY 29.45
−6.21%Margins
Gross margin
69.4%
EBITDA margin
16.6%
EBIT margin
8.8%
Net margin
9.7%
FCF margin
7.4%
4.3%
Return on equity
3.5%
Return on assets
3.7%
Return on invested capital
0.36x
Asset turnover
CNY 423.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026